How to cite item

Abiraterone survival benefit is independent of pain, prostate-specific antigen and Gleason sum in men with chemo-naïve metastatic castration-resistant prostate cancer (analysis of COU-AA-302)

  
@article{AMJ4405,
	author = {Panagiotis J. Vlachostergios and Giuseppe Galletti and Scott T. Tagawa},
	title = {Abiraterone survival benefit is independent of pain, prostate-specific antigen and Gleason sum in men with chemo-naïve metastatic castration-resistant prostate cancer (analysis of COU-AA-302)},
	journal = {AME Medical Journal},
	volume = {3},
	number = {4},
	year = {2018},
	keywords = {},
	abstract = {Advanced prostate cancer (PC), including metastatic castration-resistant prostate cancer (mCRPC) represents the lethal form of PC, yet remains largely dependent on androgen signaling (1). Abiraterone acetate (AA) is a steroid 17-hydroxylase/C17,20-lyase (CYP17) inhibitor targeting testicular, adrenal and intratumoral androgen production.},
	url = {http://amj.amegroups.com/article/view/4405}
}